PT  - JOURNAL ARTICLE
AU  - De Smet, K.
AU  - De Smet, D.
AU  - Demedts, I.
AU  - Bouckaert, B.
AU  - Ryckaert, T.
AU  - Laridon, E.
AU  - Heremans, B.
AU  - Vandenbulcke, R.
AU  - Gryspeerdt, S.
AU  - Martens, G.A.
TI  - Diagnostic power of chest CT for COVID-19: to screen or not to screen
AID  - 10.1101/2020.05.18.20097444
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.18.20097444
4099  - http://medrxiv.org/content/early/2020/05/24/2020.05.18.20097444.short
4100  - http://medrxiv.org/content/early/2020/05/24/2020.05.18.20097444.full
AB  - Background chest CT is increasingly used for COVID-19 screening in healthcare systems with limited SARS-CoV-2 PCR capacity. Its diagnostic value was supported by studies with methodological concerns and its use is controversial. Here we investigated its potential to diagnose COVID-19 in symptomatic patients and to screen asymptomatic patients in a prospective study with minimal selection bias.Methods From March 19, 2020 to April 20, 2020 we performed parallel SARS-CoV-2 PCR and CT with categorization of COVID-19 suspicion by CO-RADS, in 859 patients with COVID-19 symptoms and 1138 controls admitted to the hospital for COVID-19 unrelated medical urgencies. CT-CORADS was categorized on a 5-point scale from 1 (very low suspicion) to 5 (very high suspicion). AUC under ROC curve were calculated in symptomatic versus asymptomatic patients to predict positive SARS-CoV-2 positive PCR and likelihood ratios for each CO-RADS score were used for rational selection of diagnostic thresholds.Findings CT-CORADS had significant (P<0.0001) diagnostic power in both symptomatic (AUC=0.891) and asymptomatic (AUC=0.700) patients hospitalized during SARS-CoV-2 peak prevalence. In symptomatic patients (41.7% PCR+), CO-RADS ≥ 3 detected positive PCR with high sensitivity (89.1%) and 72.5% specificity. In asymptomatic patients (5.3% PCR+), a CO-RADS score ≥ 3 detected SARS-CoV-2 infection with low sensitivity (45.0%) but high specificity (88.8%).Interpretation CT-CORADS has meaningful diagnostic power in symptomatic patients, supporting its application for time-sensitive triage. Sensitivity in asymptomatic patients is insufficient to justify its use as screening approach. Incidental detection of CO-RADS ≥ 3 in asymptomatic patients should trigger reflex testing for respiratory pathogens.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialB1172020000008Funding StatementThis work was supported by a donation from Fagron (Nazareth, Belgium), a healthcare company, to RADar, the teaching and education initiative of AZ Delta General Hospital, to be used as unconditional research grant for data collection, collaborative collaboration and open access publication. The sponsor had no influence on the study design, data interpretation and drafting of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the AZ Delta ethical committee (Institutional Review Board) under IRB Clinical Trial Number: B1172020000008All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSource data discussed in the paper are available on email request to the guarantor of this study.